Ubenimex restrained EMT process to reduce migratory and invasive abilities of CDDP-resistant GC cells by alleviating the activation of the CD13/EMP3 /PI3K/AKT/NF-κB pathway. The gene discussed is AKT1; the disease is gastric cancer.